Optiver Holding B.V. Novartis Ag Transaction History

Optiver Holding B.V.

$3.89 Billion
Q3 2024

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$92.57 - $107.37 $811,468 - $941,205	8,766 Added 4.17%	219,044 $23.3 Million
Q1 2024 May 09, 2024	SELL	$95.27 - $108.47 $25.9 Million - $29.5 Million	-271,899 Reduced 56.39%	210,278 $20.3 Million
Q4 2023 Feb 13, 2024	BUY	$92.27 - $101.54 $27.9 Million - $30.7 Million	302,390 Added 168.19%	482,177 $48.7 Million
Q3 2023 Nov 13, 2023	BUY	$94.73 - $105.13 $17 Million - $18.9 Million	179,787 New	179,787 $18.3 Million
Q1 2023 May 11, 2023	SELL	$80.03 - $92.81 $23.9 Million - $27.7 Million	-298,790 Reduced 76.32%	92,697 $8.53 Million
Q4 2022 Feb 10, 2023	BUY	$75.55 - $92.52 $15.7 Million - $19.2 Million	207,944 Added 113.29%	391,487 $35.5 Million
Q3 2022 Nov 14, 2022	BUY	$74.61 - $87.26 $2.6 Million - $3.04 Million	34,811 Added 23.41%	183,543 $14 Million
Q2 2022 Aug 10, 2022	BUY	$80.52 - $93.75 $12 Million - $13.9 Million	148,732 New	148,732 $12.6 Million
Q1 2022 May 16, 2022	SELL	$80.11 - $90.62 $27.2 Million - $30.8 Million	-339,452 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$79.7 - $88.13 $4.39 Million - $4.85 Million	55,065 Added 19.36%	339,452 $29.7 Million
Q3 2021 Nov 15, 2021	BUY	$81.78 - $95.14 $22.3 Million - $25.9 Million	272,095 Added 2213.59%	284,387 $23.3 Million
Q2 2021 Aug 16, 2021	SELL	$85.24 - $94.15 $39.9 Million - $44.1 Million	-468,320 Reduced 97.44%	12,292 $1.12 Million
Q1 2021 May 20, 2021	SELL	$83.5 - $98.47 $1.12 Billion - $1.32 Billion	-13,404,383 Reduced 96.54%	480,612 $41.1 Million
Q1 2021 May 14, 2021	BUY	$83.5 - $98.47 $1.16 Billion - $1.37 Billion	13,884,995 New	13,884,995 $1.19 Billion

Others Institutions Holding NVS

# of Institutions

1,437

Shares Held

131M

Call Options Held

1.12M

Put Options Held

1.83M

View Full List

About NOVARTIS AG

Ticker NVS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,151,000,064
Market Cap $209B
Description
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...

More about NVS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Optiver Holding B.V., based on Form 13F filings with the SEC.

News

Stay updated on Optiver Holding B.V. with notifications on news.

Account